CHROMADEX

chromadex-logo

ChromaDex is a global nutraceutical company. They leverage its complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care, and pharmaceutical markets. They utilize in-house chemistry, regulatory, and safety consulting business units to develop commercially viable ingredients.

#SimilarOrganizations #People #Financial #Website #More

CHROMADEX

Social Links:

Industry:
Biotechnology Manufacturing Nutraceutical Product Research Wellness

Founded:
1999-01-01

Address:
Los Angeles, California, United States

Country:
United States

Website Url:
http://www.chromadex.com

Total Employee:
101+

Status:
Active

Contact:
+1 310 388 6706

Email Addresses:
custsvc@chromadex.com

Total Funding:
81.96 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Content Delivery Network Domain Not Resolving Organization Schema IPv6 Google GStatic Google Static Content Google Cloud


Similar Organizations

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.


Current Advisors List

stephen-block_image

Stephen Block Board of Directors @ ChromaDex
Board_member

rob-fried_image

Rob Fried Director @ ChromaDex
Board_member
2015-08-01

stephen-block_image

Stephen Block Member of Board of Directors @ ChromaDex
Board_member
2007-09-01

Current Employees Featured

kevin-farr_image

Kevin Farr
Kevin Farr CFO @ ChromaDex
CFO
2017-10-01

rob-fried_image

Rob Fried
Rob Fried CEO @ ChromaDex
CEO
2018-06-01

mark-friedman_image

Mark Friedman
Mark Friedman General Counsel and Secretary @ ChromaDex
General Counsel and Secretary
2018-01-01

frank-l-jaksch_image

Frank L. Jaksch
Frank L. Jaksch Co-Founder & Executive Chairman @ ChromaDex
Co-Founder & Executive Chairman
1999-09-01

Founder


frank-l-jaksch_image

Frank L. Jaksch

Stock Details


Company's stock symbol is OTCBB:CDXC

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - ChromaDex

dsm-venturing_image

DSM Venturing

DSM Venturing investment in Post-IPO Equity - ChromaDex

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - ChromaDex

Official Site Inspections

http://www.chromadex.com Semrush global rank: 2.09 M Semrush visits lastest month: 9.96 K

  • Host name: myshopify.com
  • IP address: 23.227.38.65
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "ChromaDex"

Niagen Bioscience - Wikipedia

Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. [1] The company operates in multiple sectors …See details»

Niagen Bioscience, Formerly ChromaDex | The Leader in NAD

Niagen Bioscience (formerly ChromaDex) is the premier leader in NAD+ research, clinical science, and ingredient innovation. Our ISO-accredited labs and peer-reviewed publications …See details»

Niagen Bioscience - Investor Relations - ChromaDex

Effective March 19, 2025, ChromaDex Corporation has officially changed its name to Niagen Bioscience, Inc., reflecting our sharpened focus on pioneering NAD+ science and our flagship ingredient Niagen®. In conjunction with this …See details»

ChromaDex - Crunchbase Company Profile & Funding

ChromaDex is a global nutraceutical company. They leverage their complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient …See details»

ChromaDex Corp. Announces Name Change to Niagen Bioscience, …

Mar 13, 2025 ChromaDex CEO, Rob Fried, will participate on the Longevity and Supplementation Panel on Monday, March 17, at 12:00 PM PT (3:00 PM ET). Panels will be …See details»

ChromaDex Company Profile - Office Locations, Competitors

Oct 29, 2024 ChromaDex has 5 employees across 4 locations and $99.6 m in annual revenue in FY 2024. See insights on ChromaDex including office locations, competitors, revenue, …See details»

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of ...

Mar 19, 2025 Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging …See details»

ChromaDex - 2025 Company Profile, Funding & Competitors

Mar 20, 2025 ChromaDex - Developer of nutritional ingredients for health and wellness. Public Company. Raised a total funding of $3.39M over 22 rounds from 5 investors. Founded by …See details»

ChromaDex Completes Name Change to Niagen Bioscience

Mar 19, 2025 Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key …See details»

ChromaDex - Overview, News & Similar companies | ZoomInfo.com

Jun 7, 2024 ChromaDex contact info: Phone number: (310) 388-6706 Website: www.chromadex.com What does ChromaDex do? ChromaDex is the world leader in the …See details»

ChromaDex - The Org

ChromaDex combines unsurpassed reference standards, state-of-the-art analytical testing, and authoritative source consulting with scientifically-proven ingredients to improve health and enhance life for all. We’re publicly traded, …See details»

ChromaDex - Funding, Financials, Valuation & Investors

Sep 30, 2020 ChromaDex is a provider of phytochemical standards, botanical materials, and research-grade materials for the natural products industry. New. Resources. ... How much …See details»

ChromaDex Corp - American Society for Nutrition

ChromaDex Corp. is a global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on the science of healthy aging and a leading member of ASN’s ... directives include …See details»

Chromadex - VentureRadar

" ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary …See details»

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of ...

LOS ANGELES, March 19, 2025--Niagen Bioscience, Inc. (Nasdaq: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the …See details»

About - ChromaDex

ChromaDex is the world leader in the emerging NAD space. ChromaDex has over 140 partnerships with leading universities and research institutions around the world including the …See details»

ChromaDex Celebrates 25 Years of Innovation and Pioneering …

Commemorating a quarter of a century with an exclusive 25% off lifelong subscription on Tru Niagen ® ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine …See details»

Standards Overview - ChromaDex

The ChromaDex reference standards division was established in 1999 to supply phytochemical reference standards for the dietary supplements industry, we now list over 3000 items in our …See details»

Synthesis & Isolation | ChromaDex

This Contract Research Service is ideal for any sized organization that wants to leverage the experience of our expert team to solve problems or to aid in the development of new products. …See details»

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of ...

Mar 19, 2025 Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging …See details»

linkstock.net © 2022. All rights reserved